Welcome to our dedicated page for Fortrea Holdings SEC filings (Ticker: FTRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Fortrea Holdings Inc. (NASDAQ: FTRE) files a variety of reports and disclosures with the U.S. Securities and Exchange Commission as a public company. This SEC filings page brings those documents together and adds AI-powered summaries to help readers understand the information that Fortrea provides through its regulatory filings.
Fortrea’s filings include current reports on Form 8-K, which disclose material events such as quarterly financial results, tender offers for senior secured notes, amendments to equity inducement award plans and changes in the composition of the board of directors or executive leadership. These 8-Ks often reference accompanying press releases that describe Fortrea’s revenues, net income or loss, adjusted financial measures, guidance and other operating details.
As a NASDAQ-listed issuer in the Professional, Scientific, and Technical Services sector, Fortrea also files annual reports on Form 10-K and quarterly reports on Form 10-Q. These periodic reports provide more comprehensive discussions of the company’s clinical development solutions, risk factors, financial statements and management’s analysis of results. Over time, they document how Fortrea manages its contract research organization activities and capital structure.
On this page, AI-generated highlights can help explain key points from lengthy filings, such as the implications of a debt tender offer, the nature of an inducement award plan, or the significance of board and executive changes. Users can also review information about securities registered under Section 12(b), including Fortrea’s common stock and rights to purchase Series A preferred stock.
In addition, this page provides access to filings that may relate to compensation arrangements, governance policies and other matters relevant to investors and analysts who follow FTRE. Real-time updates from the SEC’s EDGAR system, combined with AI summaries, are intended to make Fortrea’s regulatory disclosures easier to navigate and interpret.
Fortrea Holdings Inc. expanded its board and appointed William J. Sharbaugh as a Class III director, with his term running until the 2026 Annual Meeting of Stockholders or until a successor is elected. The board size was increased to eight directors. Mr. Sharbaugh brings more than three decades of pharmaceutical industry experience across finance, operations, manufacturing, quality, and clinical research organizations, and currently serves on several industry boards. At the time of disclosure he was not named to board committees and will be compensated under the company’s non-employee director compensation policy. The company disclosed no related-party transactions or family relationships requiring disclosure and furnished a press release as an exhibit.
Fortrea Holdings Inc. (FTRE) reporting person Robert Parks, Chief Accounting Officer, had Restricted Stock Units (RSUs) settle into common stock and completed a sell-to-cover tax withholding sale. On 09/15/2025, 24,934 RSUs vested and were settled into 24,934 shares at $0 per RSU as part of scheduled vesting. On 09/16/2025, Parks sold 7,338 shares at a weighted-average price of $9.95 to satisfy tax withholding required by the company’s equity plan. After these transactions, Parks beneficially owned 19,046 shares and held an aggregate 67,721 RSUs (remaining unvested). The Form 4 was signed by an attorney-in-fact on 09/17/2025.
Fortrea Holdings Inc. (FTRE) filed a Form 144 reporting a proposed sale of 7,338 shares of common stock through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $73,007.96. The shares were acquired on 09/15/2025 upon restricted stock vesting from the issuer and the payment type is listed as compensation. The filing also discloses a recent sale of 592 shares on 09/09/2025 for gross proceeds of $6,055.63. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Fortrea Holdings (FTRE) insider Robert Parks reported settlement and partial sale of restricted stock units. On 09/08/2025 Mr. Parks had 2,042 RSUs settle into 2,042 shares of common stock, increasing his direct holdings to 92,655 RSUs (aggregate RSU count) and 2,042 shares reported following settlement. On 09/09/2025 he executed a sell-to-cover of 592 shares at a weighted-average price of $10.23 to satisfy tax withholding, leaving 1,450 shares held directly. The RSUs vested on 09/06/2025 with a remaining installment vesting 09/06/2026. All trades were routine equity-compensation transactions and the sales were not discretionary.
Fortrea Holdings insider transaction summary: General Counsel James S. Hanson received 5,788 Restricted Stock Units (RSUs) that vested and settled into 5,788 shares of Fortrea common stock on September 8, 2025. Following settlement, Hanson sold 1,677 shares on September 9, 2025 at a weighted average price of $10.23 per share to satisfy tax withholding obligations under the companys equity plan. After these actions, Hanson directly beneficially owns 19,092 shares and holds an aggregate 47,167 RSUs (with a second installment vesting on September 6, 2026). The Form 4 is signed by Hanson on September 10, 2025.
Mark A. Morais, Chief Operating Officer of Fortrea Holdings Inc. (FTRE), reported settlement of restricted stock units (RSUs) and a related sell-to-cover transaction. On 09/08/2025, 7,156 RSUs vested and were settled into 7,156 shares of Common Stock at no cash price. On 09/09/2025 the reporting person sold 3,155 shares at a weighted average price of $10.23 to satisfy tax withholding obligations under the company’s equity plan. After these transactions the reporting person beneficially owned 56,976 shares of Common Stock directly and 4,625 indirectly through a spouse, with 7,156 RSUs settled and an aggregate 81,476 RSUs/underlying shares noted as held. The sales were described as mandatory "sell-to-cover" actions, not discretionary trades.
Fortrea Holdings insider Jill G. McConnell settled restricted stock units and sold shares to cover withholding taxes. On 09/08/2025 Ms. McConnell had 7,156 RSUs settle into Common Stock at no cash cost, increasing her reported beneficial ownership to 61,926 shares. The next day, 09/09/2025, she sold 3,156 shares in a company-mandated "sell-to-cover" to satisfy tax withholding at a weighted average price of $10.23, leaving 58,770 shares beneficially owned. The filing notes the RSU vesting was scheduled and the sell-to-cover was required under the issuer's equity plan. The RSUs reflect additional installments with a second installment vesting on 09/06/2026.
Fortrea Holdings Inc. (FTRE) Form 144 notice shows a proposed sale of 3,155 common shares, with an aggregate market value of $32,272.81, to be sold on 09/09/2025 on NASDAQ. The shares were acquired on 09/08/2025 through restricted stock vesting and are labeled as compensation. The filer also reported a prior sale on 08/19/2025 of 4,886 shares for gross proceeds of $39,160.31. The filing includes a representation that the seller is not aware of undisclosed material adverse information about the issuer.
Form 144 filed for Fortrea Holdings Inc. (FTRE) reports a proposed sale of 592 shares of common stock with an aggregate market value of $6,055.63. The filer acquired these shares on 09/08/2025 by restricted stock vesting from the issuer and lists the nature of payment as compensation. The filing identifies Fidelity Brokerage Services LLC as the broker and indicates an approximate sale date of 09/09/2025 on NASDAQ. The form notes there were no securities sold by the person in the past three months and includes the standard signer representation regarding material nonpublic information.
Fortrea Holdings Inc. (FTRE) filed a Form 144 to notify a proposed sale of common stock. The filer plans to sell 1,677 shares through Fidelity Brokerage Services with an aggregate market value of $17,154.20, representing part of 90,800,000 shares outstanding. The approximate sale date is 09/09/2025. The shares were acquired on 09/08/2025 through restricted stock vesting from the issuer and the payment is described as compensation. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
FAQ
What is the current stock price of Fortrea Holdings (FTRE)?
What is the market cap of Fortrea Holdings (FTRE)?
